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Niﬂumic acidCLC-K chloride channels and their subunit, barttin, are crucial for renal NaCl reabsorption and for inner ear endo-
lymph production. Mutations in CLC-Kb and barttin cause Bartter syndrome. Here, we identiﬁed two adjacent
residues, F256 and N257, that when mutated hugely alter in Xenopus oocytes CLC-Ka's biphasic response to
niﬂumic acid, a drug belonging to the fenamate class, with F256A being potentiated 37-fold and N257A being
potently blocked with a KD ~ 1 μM. These residues are localized in the same extracellular I–J loop which harbors
a regulatory Ca2+ binding site. This loop thus can represent an ideal and CLC-K speciﬁc target for extracellular
ligands able to modulate channel activity. Furthermore, we demonstrated the involvement of the barttin subunit
in theNFApotentiation. Indeed the F256Amutation confers onto CLC-K1 a transient potentiation induced byNFA
which is found only when CLC-K1/F256A is co-expressed with barttin. Thus, in addition to the role of barttin in
targeting and gating, the subunit participates in the pharmacological modulation of CLC-K channels and thus
represents a further target for potential drugs.
© 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
CLC-K channels belong to the family of CLC proteins that is responsi-
ble for transepithelial and intracellular Cl− transport in several tissues
and organs. So far four isoforms have been electrophysiologically char-
acterized: human CLC-Ka/CLC-Kb and the rodent (rat and mouse) CLC-
K1 [1–3]. CLC-K channels are expressed in the kidney [1,2,4] and in the
inner ear [5] where they are involved in NaCl reabsorption [6] and in
the production of the endolymph [7,8], respectively. They co-localize
with the β-subunit, barttin [5], a small protein that affects CLC-K traf-
ﬁcking, stability, and gating by unknown mechanisms [5,9–12]. CLC-K
channels are modulated by external Ca2+ and pH. CLC-K currents in-
crease by increasing [Ca2+]ext, while they are blocked by external acid-
iﬁcation or extreme alkalinization [4,5,13–15]. The association of loss of
function mutations of CLC-Kb and barttin with Bartter syndrome, types
III and IV respectively [9,16], and the proposal that gain of function mu-
tations may favor hypertension [17,18] encouraged studies aimed to
identify CLC-K activators and inhibitors. By a detailed pharmacological
investigation performed on CLC-K channels expressed in Xenopus oo-
cytes, CPP derivatives, DIDS and ﬂufenamic acid, an anti-inﬂammatoryd; DIDS, diisothiocyanato-2,2′-
ic acid; CPA, p-chlorophenoxy-
ax: +39 0106475 500.
. This is an open access article underdrug belonging to the class of fenamates, were found to inhibit CLC-Ka
[19–23]. Interestingly, niﬂumic acid (NFA), another member of the
same class of fenamates, is the most potent CLC-K opener so far identi-
ﬁed [19,24,25]. Each CLC-K isoform shows a different response to extra-
cellular NFA: [NFA]ext ≤ 0.5 mM increases CLC-Ka currents whereas
higher concentrations block this channel [19]; hCLC-Kb is potentiated
by [NFA]ext up to 2 mM [19]; and rat CLC-K1 is blocked at all concentra-
tions tested [24]. The biphasic NFA action on CLC-Ka has been explained
by two separate binding sites for NFA that are involved in the block and
potentiation of the channel, respectively [19]. These binding sites are
distinct from that known for CPP derivatives and FFA [24]. By a muta-
genic screen on CLC-Ka three residues (L155, G345, A349) were identi-
ﬁed that when mutated decreased NFA potentiation and could thus
participate in the potentiating binding site or be involved in conforma-
tional changes associated with potentiation [25]. Surprisingly, NFA no
longer potentiated currents of hCLC-Ks expressed in mammalian cells
[26]. In order to identify themolecular determinants of CLC-K activation,
here we further investigated NFA potentiation of CLC-Ks in oocytes, the
model system where hCLC-K potentiation was found. A further incen-
tive for our study came from the identiﬁcation of four acidic residues,
located in (or close to) the I–J loop of the channel, that form an
intersubunit Ca2+ binding site [14,27]. The I–J loop connects the two
halves with opposite orientation (B–I and J–Q) of a CLC monomer [28].
Since Ca2+ regulation is found only in CLC-Ks among CLC proteins, we
hypothesized that the I–J loop might be involved in the channelthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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jacent residues of the I–J loop, F256 and N257, that when mutated alter
NFA potentiation. Mutant F256A dramatically increases the NFA activa-
tion of CLC-Kawhereas N257A is only blocked byNFAwith high afﬁnity.
Using CLC-K1, which shows functional expression also without barttin,
we demonstrated the involvement of barttin in CLC-K potentiation by
NFA. Finally, the F256A CLC-Ka mutant partially recovered the biphasic
NFA response of CLC-Ka expressed in HEK293 cells, conﬁrming F256 in-
volvement in the potentiation by NFA. F256, N257 and three of the res-
idues forming the Ca2+ binding site are localized in the I–J loop. Thus,
this loop represents an interesting pharmacological target for extracel-
lular CLC-K ligands.
2. Materials and methods
2.1. Molecular biology
Mutationswere inserted by recombinant PCR as described previous-
ly [29].
For expression in Xenopus oocytes: after linearization, cRNA of CLC-K
channels and barttin subunit were transcribed by mMessage mMachine
SP6 kit and T7 RNApolymerase (Ambion), respectively. CLC-K constructs
were co-expressed with barttin mutant Y98A [5], except CLC-K1 con-
structs that could be expressed also by themselves.
For the CLC-K expression in HEK293 cells: F256A CLC-Ka and barttin
constructs were subcloned in the pcDNA3 vector.
2.2. Electrophysiology
After cRNA injection [23], oocytes were kept at 18 °C in the main-
taining solution containing (in mM): 90 NaCl, 2 KCl, 1 MgCl2, 1 CaCl2,
and 10 Hepes at pH 7.5. One to three days after injection voltage clamp
measurementswere performedby using the customacquisition program
GePulse (available at http://users.ge.ibf.cnr.it/pusch/programs-mik.htm)
and a Turbo TEC-03X ampliﬁer (npi electronic, Tamm, Germany). The
standard bath solution contained (in mM): 90 NaCl, 10 CaCl2, 1 MgCl2,
and 10 Hepes at pH 7.3 (osmolarity: 190 mosm). Different NFAA
F256
N257
C
Fig. 1. Localization of F256 and N257 and of the Ca2+ binding site on the homologymodel of CL
the extracellular side are indicated by two tones of gray. The residues involved in the response
are colored differently: green F256, yellowN257, red E259, blue E261, pinkD278, and black E28
and colored as in A. (C) Sequence alignment around the I–J loop of CLC-Ka, -Kb, -K1, CLC-0, anconcentrations were prepared immediately before use by diluting
niﬂumic acid that was dissolved in dimethyl sulfoxide (DMSO) in the
standard bath solution. Final [DMSO] was ≤0.2%. The holding potential
was kept at ~−30 mV corresponding to the resting membrane potential
in our conditions. To estimate CLC-K currents at different potentials, the
“IV-pulse protocol” was applied: a prepulse to −100 mV for 100 ms
was followed by voltages ranging from−140 to 80 mV with 20 mV in-
crements for 200 ms. Pulses ended with a tail to 60 mV for 100 ms.
Interpulse durationwas 1.5 s. The effect of [NFA]ext wasmonitored by ap-
plying 200ms pulses to 60mV once per second. To estimate endogenous
and leak currents a solution containing (in mM): 100 NaI, 5 MgSO4, and
10 Hepes at pH 7.3 was applied [22].
HEK293 cells were co-transfected with three plasmids encoding
F256ACLC-Ka, barttin, andGFP, respectively. The latter allowed the iden-
tiﬁcation of transfected cells by their ﬂuorescence. Two to three days
after transfection, whole-cell patch-clamp recordings were performed.
Pipettes were pulled from borosilicate glass capillaries (Hilgenberg,
Malsfeld, Germany) and had resistances of 2.0–2.7 MΩ in the recording
solutions. Experiments in which series resistance led to voltage errors
larger than a fewmVwere discarded. The extracellular standard bath so-
lution contained (in mM): 145 NaCl, 2 CaCl2, 2 MgCl2, and 10 Hepes at
pH 7.3 (osmolarity: 277 mOsm). The intracellular solution contained
(in mM): 130 CsCl, 2 EGTA, 2 MgCl2, and 10 Hepes at pH 7.3 (osmolarity
233 mOsm). F256A CLC-Ka currents were assayed with the following
stimulation protocol: after a prepulse to 60 mV for 20 ms, channels
were stimulated with potentials ranging from−140 to 80 mV with 20
mV increments for 200 ms. Pulses ended with a tail pulse to 80 mV for
50 ms. Holding potential was 0 mV. To evaluate the effect of NFA, CLC-
Ks were stimulated with repetitive 10 ms pulses to 60 mV delivered
once per second. Leak currents were evaluated applying a solution that
blocks speciﬁcally CLC-Ks [22] containing (in mM): 140 NaI, 2 CaCl2, 2
MgSO4, and 10 Hepes at pH 7.3.
2.3. Data analysis
Currents recorded at different [NFA]extwere normalized to the steady
state currents measured at 60 mV in control conditions. NormalizedB
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C-Ka. (A) Surface representation of the CLC-Kamodel [27]. The two subunits viewed from
to NFA (F256 and N257) and those that coordinate Ca2+ (E259, E261, D278, E281) [14,27]
1. (B) Zoomof the region containing the residues of interest. Residues are depicted as sticks
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Fig. 2. F256A CLC-Ka is hugely activated by NFA. (A–C) Effect of NFA on F256A and WT
CLC-Ka in Xenopus oocytes. Typical currents of F256A (A) andWT CLC-Ka (B) in response
to the IV-protocol (top) in control (left) and at 200 μM NFA (right). The inset (A) shows
F256A currents at high magniﬁcation (C) Dose–response relationship of NFA modulation
of WT and F256A CLC-Ka. The currents acquired at 60 mV are normalized to values mea-
sured in standard solution (i.e. 0 NFA) and plotted versus [NFA]ext (used concentrations: 1,
2, 5, 10, 50, 200, 500, 1000 and 2000 μM) (n ≥ 3).
A
B
C NFA 
50 pA  
50 ms
100 pA2
50 ms
Current
Variance
Control
200 pA  
100 ms
Control 200 µM NFAext
D
50 pA  
50 ms
100 pA2
50 ms
Variance
Current
-100 mV 60 mV
)Ap(
i
0
1
2
3
4
control
NFA
Current (pA)
0 25 50 75 100
Ap(
ecnairaV
2 )
0
50
100
150
Current (pA)
0 25 50 75 100
Ap(
ecnairaV
2 )
0
50
100
150
200
0 60mV 60mV
80mV
-140mV
F256A ClC-Ka / barttin
0
Fig. 3.Non-stationary noise analysis of F256A CLC-Ka. (A) Typical current traces recorded
by patch clamp in conﬁguration inside-out from different oocytes without NFA (left) and
with 200 μMNFAext (right) evoked by the stimulation protocol (bottom). (B–C) Examples
of non-stationary noise analysis of F256A CLC-Ka in standard conditions (B) and in the
2747A. Gradogna et al. / Biochimica et Biophysica Acta 1838 (2014) 2745–2756currents were plotted versus [NFA]ext. Leak currents were subtracted.
Error bars indicate SD.presence of 200 μM NFAext (C) at 60 mV. (left). Mean currents (upper) and variance
(lower) are shown as a function of time. Right: Variance (symbols) is plotted versus the
mean current and ﬁtted with a parabola (red line) as described in the Materials and
methods section. (D) Bars represent the absolute value of the single channelmean current
in control solution and at 200 μMNFAext at two different potentials (−100mVand 60mV)
(n ≥ 4), p N 0.2 (unpaired Student's t-test) (background variance and leak currents were
subtracted).2.4. Noise analysis
Patch-clamp measurements were performed in the inside-out
conﬁguration on Xenopus oocytes. The intracellular (bath) solution
contained (in mM): 100 N-methyl-D-glucamine-Cl (NMDG-Cl), 2
MgCl2, 2 EGTA, and 10 Hepes at pH 7.3. The extracellular (pipette) solu-
tion contained (in mM): 90 N-methyl-D-glucamine-Cl (NMDG-Cl), 10
CaCl2, 1 MgCl2, and 10 Hepes at pH 7.3. To estimate the effect of NFA
on F256A andN257A CLC-Ka 200 and 4 μMNFAwere dissolved in extra-
cellular solution, respectively. In the experimentswith F256ACLC-Ka an
intracellular solution in which Cl−was replaced by glutamate was used
to evaluate endogenous and leak currents; the same aim was obtainedin the experiments on N257A CLC-Ka by using an intracellular solution
in which 2 mM CPA (p-chlorophenoxy-acetic acid) was dissolved. Patch
pipettes were pulled from aluminosilicate glass capillaries (Hilgenberg,
Malsfeld, Germany) and had resistances of 0.8–1.5 MΩ in the recording
solutions. F256A and N257A CLC-Ka currents were assayed with the fol-
lowing stimulation protocol: after a prepulse to 60 mV for 200 ms,
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Fig. 4. NFA increases the open probability of F256A CLC-Ka. Example of single channel recordings and analysis from a single patch (similar experiments allowing the estimation of the
number of channels: n = 3; 2 additional patches with larger currents were allowed to estimate the degree of potentiation but not the number of channels). (A) Continuous recording
from F256A CLC-Ka at 60 mV. Different colors represent the external solutions applied during the experiment (black: control, red: 200 μM NFA). (B) Portions of the recording in
(A) shown at higher time resolution. (C) The amplitude histogram of the recording at 60 mV in control solution (black trace) and in the presence of 200 μM NFA (red trace). Fit curves
are superimposed as dashed lines. (D) Mean current from the recording in (A) measured at 60 mV for 40 s in control solution and in 200 μMNFA. (E–F) Probabilities of the conductance
states in 200 μMNFA and in control solution. The measured state probabilities are shown as bars, whereas the symbols are the expected values from the binomials ﬁts (see the Materials
andmethods section) resulting inN=5 channels, p=20% inNFA andp=0.3% in control (for theﬁt in control, the number of channelswasﬁxed to 5, as obtained in the presence of NFA).
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with 20 mV increments for 500 ms. Pulses ended with a tail pulse to
60 mV for 200 ms. To estimate the single-channel current by non-
stationary noise analysis the following stimulation protocolwas applied
100–200 times: a prepulse to 60mVwas followedby apulse to−100mV
for 300 ms. Pulses ended with a tail at 60 mV for 200 ms. Currents wererecorded at 50 kHz afterﬁltering at 10 kHzwith an eight-pole Besselﬁlter.
An intracellular solution inwhich 100 μMCPAwas dissolvedwas used for
the measurements on N257A CLC-Ka to induce current relaxations. Data
analysis was performed at−100 mV and 60 mV; holding potential was
0 mV. First the mean current, Iwas calculated. The variance, σ2, was es-
timated from the averaged squared difference of consecutive traces
WT 
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WT 
ClC-K1/barttin
A B
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NFA
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[NFA] (µM)
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Control
NFA 200 µM 
Fig. 5.WT CLC-K1 is blocked by NFA both with and without barttin. Effect of 200 μMNFA
onWTCLC-K1/barttin (A) andWTCLC-K1 (B). Currents are plotted as function of the time.
Colors and symbols correspond to the different solutions applied during the experiment.
(C) Dose response of NFA effect onWT CLC-K1with andwithout barttin. Currents normal-
ized to those recorded in standard solution are plotted versus [NFA]ext (concentrations
tested on CLC-K1/barttin: 10, 50, 200, 2000 μM, n ≥ 3; concentrations tested on CLC-K1:
10, 200 μM, n ≥ 3).
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was assembled by binning as described previously [30]. Finally the
variance–mean plot was ﬁtted by σ2 = iI− I2 / N, with the single chan-
nel current, i, and the number of channels, N, as free parameters [31].2.5. Single channel analysis
Single channel measurements were performed on Xenopus oocytes
in outside-out and inside-out conﬁguration to study the effect of extra-
cellular NFA on F256A CLC-Ka and intracellular CPA on N257A CLC-Ka,
respectively. The intracellular solution was the same as used for the
noise analysis. For the outside-out recordings, the extracellular solution
contained (in mM): 92 tetraethylammonium chloride (TEA-Cl), 10
CaCl2, and 10 Hepes at pH 7.3. Pipettes were pulled from borosilicate
glass capillaries (Hilgenberg, Malsfeld, Germany) and had resistances
of 9–10 MΩ in the recording solution. The outside-out recordings
of F256A were performed at 60 mV in continuous local perfusion
switching between control and NFA containing external solution. For
the inside-out experiments of N275A, the extracellular solution
contained (in mM): 92 N-methyl-D-glucamine-Cl (NMDG-Cl), 10
CaCl2, and 10 Hepes at pH 7.3 and pipettes had resistances of 3–4 MΩ
in the recording solution. Inside-out recordings of N257A were per-
formed at−100mV in continuous perfusion with intracellular solution
with or without CPA. Currents were ﬁltered at 3 kHz and sampled at
50 kHz. Single channel analysis was performed as described by Ludewiget al. [32]. Brieﬂy, after digital ﬁltering at 600 Hz, amplitude histograms
were manually ﬁtted by Gaussian functions using custom software. The
respective area of each Gaussian component was used to calculate the
open probability, p(k), of each conductance state k (k = 0 refers to
the baseline). These were used to obtain the number of channels and
the open probability by optimizing the parameters N and p in the fol-
lowing equation, describing a binomial distribution:
p kð Þ ¼ Nk
 
pk 1−pð ÞN−k:
3. Results
3.1. The F256A mutation hugely increases CLC-Ka potentiation by NFA in
Xenopus oocytes
The identiﬁcation of an intersubunit Ca2+ binding site in the I–J loop
[14,27] (Fig. 1A–C) motivated us to investigate if the I–J loop might be
involved also in the channel modulation by NFA. We identiﬁed two ad-
jacent, externally exposed residues, F256 and N257 (Fig. 1A, B), that
when mutated dramatically changed the CLC-Ka response to NFA.
F256A CLC-Ka expressed in Xenopus oocytes yields currents similar to
those of WT regarding both kinetics and magnitude (Fig. 2A inset).
However, at 200 μM NFA F256A and WT currents increase ~25-fold
(Fig. 2A) and 3-fold (Fig. 2B), respectively. The activating effect of NFA
was so marked that F256A currents in the absence of NFA had to
be b1 μA to avoid series resistance problems after adding NFA (Fig. 2A,
left). Both WT and F256A CLC-Ka show maximal stimulation at
500 μM NFA (4-fold and 37-fold, respectively) (Fig. 2C). However the
F256A mutant is potentiated by NFA at all the concentrations tested
(from 1 to 2000 μM) (Fig. 2C) with a two-fold potentiation already at
2 μM. Instead WT currents are not changed by very low [NFA]ext and
are inhibited by [NFA]ext N 500 μM(Fig. 2C). The less pronounced poten-
tiation at high [NFA]ext indicates that potentiation and block coexist also
for this mutant as for WT (Fig. 2C). An important question is whether
NFA affects directly the ion permeation or whether it acts indirectly
modifying the open probability of F256A CLC-Ka. By using patch-clamp
experiments in the inside-out conﬁguration and non-stationary noise
analysis we estimated the single channel current without and with
NFA (Fig. 3). NFA does not change the current kinetics of F256A CLC-Ka
(Fig. 3A). By repetitive pulses to 60 mV after a prepulse to−100 mV
mean current and variance (Fig. 3B and C, left) were estimated. The sin-
gle channel current was estimated from the ﬁt of a parabola to the vari-
ance–mean plot (Fig. 3B and C, right), as described in the Materials and
methods section. The fact that the variance–mean plots in control as
well as in the presence of NFA showed no sign of curvature suggests
that even after the dramatic potentiation by NFA the open probability
of the F256A mutant is signiﬁcantly below 0.5, and impossible to esti-
mate from this analysis. Importantly, both at negative and positive po-
tentials, 200 μM NFA does not change signiﬁcantly the conductance of
F256A CLC-Ka (Fig. 3D). This suggests that an allosteric increase of
open probability is responsible for NFA effect on F256A CLC-Ka. To
conﬁrm this hypothesis we performed single channel recordings in the
outside-out conﬁguration (Fig. 4). Fig. 4A shows a typical recording. In
the absence of NFA channel activity is low, showing a single open con-
ductance level of ~1.6 pA (average: 1.55 ± 0.06 pA (n = 3)) (Fig. 4A, B
left, C), in agreement with the noise analysis. Channel openings are
very ﬂickery as evidenced by a large width of the corresponding Gauss-
ian component (Fig. 4C). Application of 200 μMNFA immediately (with-
in the time of a few seconds needed to change the solution) dramatically
increases themean current in the patch about 53-fold (Fig. 4D) (average
current increase: 39+/− 13 (SD); n= 5 patches). Interestingly, the po-
tentiation is quickly reversed upon washout of NFA (Fig. 4A) demon-
strating that it does not reﬂect an increase of the number of channels
present in the patch. Qualitatively, the multiple conductance levels
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(C–E)NFA effect on F256A CLC-K1 expressedwith barttin or by itself inXenopus oocytes. Current of F256ACLC-K1/barttin (C) and F256ACLC-K1 (D) at 60mV is shown as function of time.
Colors and symbols correspond to the solutions applied. Vertical arrows indicate the initial current (I0), the maximal NFA potentiation extrapolated by a single-exponential function (I1),
and the steady state current (I2). (E) Dose–response relationship of NFApotentiation of F256A/barttin CLC-K1 andNFA inhibition of F256A CLC-K1/barttin and F256A CLC-K1. I1/I0 and I2/I0
are plotted versus [NFA]ext (used concentrations: 10, 50, 200, and 2000 μM, n≥ 3). The lines represent the ﬁt curves obtained from the equation I2 / I0 = 1 / (1+ (c / KD)) for NFA block of
F256A/barttin (KD ~ 142 μM) and F256A (KD ~ 33 μM).
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channel conductance. This is conﬁrmed by the analysis of the ampli-
tude histogram (Fig. 4C), which can be well ﬁtted by the super-
position of roughly equally spaced Gaussian components with a
distance of 1.8 pA, again in good agreement with the noise analysis
and demonstrating that NFA has almost no effect on the single chan-
nel conductance (average: 1.75 ± 0.10 pA (n = 3) in NFA). Im-
portantly, the amplitude histogram analysis allows to obtain an
estimate of the absolute open probability of mutant F256A. For the
patch shown in Fig. 4, in the presence of NFA, the occupation proba-
bilities of the various conductance levels obtained from the Gaussian
ﬁt (Fig. 4E, bars) can be well ﬁtted (see the Materials and methods
section) assuming the presence of 5 independent and identical chan-
nels each having an open probability of pNFA = 20% (Fig. 4E, triangles).
Assuming the same number of channels in the absence of NFA yields an
open probability of p = 0.3% (Fig. 4F). The average open probability
obtained by this method is p = 0.6 +/− 0.3% (n = 3; SEM) in the ab-
sence of NFA.
The dramatic increase of NFA potentiation and the very strong inter-
action seen with the F256A mutant suggest that the I–J loop may be
involved in the NFA induced effects.3.2. In CLC-K1 potentiation of F256A by NFA requires barttin
Unlike human CLC-Ks, rat CLC-K1 exhibits functional expression also
without barttin [2,33]. Thus CLC-K1 is ideal to reveal possible barttin
involvements in CLC-K regulation. CLC-K1/barttin [24] as well as CLC-
K1 without barttin yields currents at 10 μM and 200 μM NFA that are
about 80% and 45% of those recorded in control conditions (Fig. 5). We
inserted the mutation F256A in the CLC-K1 background to test if this
substitution could induce NFA potentiation also of this channel. F256A
CLC-K1with (Fig. 6A) andwithout barttin (Fig. 6B) shows functional ex-
pression levels and kinetics comparable with those of WT with and
without barttin. Interestingly, the application of 10 μM NFA caused a
transient potentiation of F256A CLC-K1/barttin (Fig. 6C), even though
steady state currents were not increased. Thus the F256A mutation in-
duces potentiation in the CLC-K1 background. Surprisingly, no potentia-
tion was found when F256A CLC-K1 was expressed without barttin
(Fig. 6D). As illustrated in Fig. 6C and D, we separated the transient po-
tentiating effect of NFA and the blocking effect [24], with the results
shown in Fig. 6E. The maximal potentiation is estimated around 1.9
fold. The apparent NFA blocking effect on F256A CLC-K1 is weakly more
pronounced (KD ~ 33 μM) than on F256A CLC-K1/barttin (KD ~ 142 μM),
A B
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10 100
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Fig. 7. NFA potentiation and block of F256A CLC-Ka in HEK293 cells. (A) Representative current recordings of F256A CLC-Ka/barttin expressed in HEK293 cells in control solution (top
right), at 20 μM NFA (bottom left) and at 500 μM NFA (bottom right). (B and C) Effect of [NFA]ext on F256A CLC-Ka. (B) Mean current at 60 mV is plotted vs. time. Colors and symbols
correspond to the [NFA]ext applied (0, 20, and 500 μM). (C) Normalized currents acquired at different [NFA]ext are plotted vs. [NFA]ext (used concentrations: 20, 50, 200, and 500 μM)
(n ≥ 4 for 20, 50, and 500 μM; n = 17 for 200 μM).
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channels co-expressed with barttin. Thus this subunit participates in
the pharmacological modulation of these channels.3.3. The F256Amutation partially restores CLC-Ka biphasic response to NFA
also in HEK cells
We had found that in HEK293 cells both human CLC-Ks and rat CLC-
K1 were inhibited by NFA at all the concentrations tested (from 0.3 to
2000 μM) [26]. We asked whether F256A mutation might restore NFA
potentiation of CLC-Ka in HEK293 cells. In HEK293 cells, the CLC-Ka
F256A mutant was overall similar to WT (Fig. 7A top), showing no
signs of time- or voltage-dependent relaxations, and differing thus
markedly in behavior compared to Xenopus oocytes [26]. Noteworthy,
F256A CLC-Ka currents increased at 20 μM NFA, whereas they were
inhibited by 500 μM NFA (Fig. 7A, B). The dose–response of the effect
of NFA conﬁrmed the biphasic modulation of this mutant by NFA with
potentiation at [NFA]ext up to 200 μM (slightly lower compared with
that found in oocytes) and inhibition at higher [NFA]ext (Fig. 7C), remi-
niscent of the biphasic response to NFA found in oocytes [19] (Fig. 2C).
These results further conﬁrm the involvement of F256 in the CLC-K po-
tentiation by NFA. However, the variability of the potentiation seen in
cells (see error bars in Fig. 7C), but not in oocytes, indicates that this pro-
cess depends on cellular factors that remain to be identiﬁed.3.4. The N257A mutation hugely increases CLC-Ka inhibition by NFA
Also the residue adjacent to F256, N257, when mutated to Ala dra-
matically changed CLC-Ka's response to NFA. Unlike F256A, N257A
CLC-Ka expressed in oocytes yields very large and voltage-independent
currents (Fig. 8A, left). The response of this mutant to NFAwas peculiar:
even as low as 5 μMNFA induced ~90% inhibition (Fig. 8A right). In fact,
N257A expressed in oocytes was only blocked at all [NFA]ext tested
(from 1 to 2000 μM)with an apparent KD ~ 1 μM (Fig. 8B). Interestingly,
N257A currents continue to decrease after a brief application of NFA
even if the drug is completelywashed out (Fig. 8C, left). The ﬁnal current
level is almost as low as that achieved with a continuous application of
NFA (Fig. 8C, right). Thus NFA binding does not cause immediate block
but rather induces a conformational change resulting in channel closure.
To test if NFA block of N257A CLC-Ka reﬂects a reduction of the
conductance or a reduced open probability, we ﬁrst performed non-
stationary noise analysis. However the lack of current kinetics of
N257A CLC-Ka (Fig. 9A left and middle) only allowed us to resolve a re-
stricted range of a putative parabola in the variance–mean plot render-
ing this approach unreliable (not shown). Thus, as a tool to introduce
current relaxations, we used p-chlorophenoxy-acetic acid (CPA), that
is known to blockCLC-0 andCLC-1 currents at negative potentials induc-
ing a closure of individual pore with only a small direct effect on the sin-
gle channel conductance [29,34,35]. In fact, 100 μM CPAint inhibits
N257A CLC-Ka at negative voltages conferring to this mutant current
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Fig. 8. Dramatic inhibition of N257A CLC-Ka by NFA. (A) Typical currents of N257A CLC-Ka expressed in Xenopus oocytes in control solution (left) and at 5 μM NFA (right).
(B) Dose–response relationship of NFA effect on N257A CLC-Ka. Normalized currents are plotted vs. [NFA]ext (used concentrations: 2, 5, 10, 50, 200, 500, and 1000 μM) (n ≥
4 except n = 3 for 1000 μM). The red line represents the ﬁt curve obtained from the equation I / I0 = 1 / (1 + (c / KD)) with KD ~ 1 μM. (C) Insensitivity to washing of N257A
CLC-Ka inhibition. Mean currents plotted as function of time after a short NFA perfusion (left) (similar experiments n= 4) or a longer NFA perfusion (right) (similar experiments
n = 10). Colors and symbols represent the solutions applied.
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(Fig. 9B and C) and that resemble the fast protopore gate of CLC-0 [36].
This approach indicates that NFA does not affect the conductance
of N257A (Fig. 9D). Interestingly, these values for N257A in the presence
of CPA are ~32–42% of those obtained for F256A without CPA (Fig. 3D).
Previously it was shown that in CLC-0 CPA induces a voltage-dependent
closure of individual protopores of the gating glutamate E166A mutant,
which lacks the regular fast gate [29,35]. Thus, the smaller conductance
seen for N257A in the presence of CPA might either reﬂect a closure of
the individual protopores or could be caused by a direct effect of themu-
tation on channel conductance. To distinguish between these hypothe-
ses, we performed single channel measurements of N257A CLC-Ka
with and without CPA (Fig. 10). In the absence of CPA, the mutant ex-
hibits very slow gating kinetics and several conductive states (Fig. 10)
that were not found for F256A, but which are of the same order of mag-
nitude of the conductance of F256A (0.4 pA–1.9 pA) (Fig. 10B, C). Thus
N257A mutation introduces a variability of the conductance levels ren-
dering difﬁcult to directly compare it with mutant F256A. In any case,
we can conclude that the much higher level of functional expression of
this mutant compared to WT does not reﬂect a substantial increase of
the single channel conductance. In the presence of CPA, channel
openings are much shorter (Fig. 10B, right) and the predominant con-
ductance level has an amplitude of ~0.66 pA (Fig. 10C). Overall, the
results from the single channel recordings are compatible with theFig. 9. Non-stationary noise analysis of N257A CLC-Ka. (A) Typical patch clamp inside-out trac
NFAext (middle), at 4 μMNFAext and 100 μM CPAint (right). (B and C) Examples of non-stationa
lution (B) and at 4 μM NFAext (C). Analysis was performed both for the deactivating currents
example at 60 mV (left). Mean currents (upper) and variance (lower) are shown as a function
parabola (red line) as described in theMaterials andmethods section. (D) Bars represent the abs
control solution and at 4 μMNFAext at twodifferent potentials (−100mVand 60mV) (n≥ 3), pnon-stationary noise analysis. The overall channel activity indicates a
relatively large open probability (Fig. 10) (~25% assuming two indepen-
dent channels in the patch). However, the multiple conductance levels
render a quantitative analysis difﬁcult.
From the combined evidence from noise analysis and single channel
recording, we can conclude that the mutation N257A by itself does not
signiﬁcantly change the single channel conductance, that the mutant
has a large constitutive open-probability (compared to WT CLC-Ka),
and that the inhibition of the mutant by NFA reﬂects a reduced open-
probability, with unaltered channel conductance.
Nextwe tested the effect of NFA onN257A in CLC-K1. Unlike for CLC-
Ka, the substitution of N257 with Ala did not modify magnitude and
kinetics of CLC-K1 currents (Fig. 11). Moreover N257A CLC-K1 with or
without barttin was only weakly more sensitive to NFA compared
withWT (Fig. 11). Thus the highNFA afﬁnity of N257A is a characteristic
of CLC-Ka.
4. Discussion
Because of the causative association of CLC-K channels with Bartter
syndrome and a proposed association with hypertension, several
works aimed at a pharmacological characterization of these channels.
Among the compounds identiﬁed, NFA was the most potent activator
of hCLC-Ks expressed in Xenopus oocytes. Surprisingly, noNFA activationes of N257A CLC-Ka measured from different oocytes in control conditions (left), at 4 μM
ry noise analysis of N257A CLC-Ka in the presence of 100 μMCPAint, in control external so-
at−100 mV as well as for the unblocking relaxations at 60 mV. The traces shown are an
of time (right). Variance (symbols) is plotted versus the mean current and ﬁtted with a
olute value of the single channelmean current in the presence of 100 μMCPAint in external
N 0.3 (unpaired Student's t-test) (background variance and leak currentswere subtracted).
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ably reﬂecting a near-maximal open probability of the channels in that
expression system. Thus, herewe further investigated theNFA activation
of CLC-Ks in oocytes to identify molecular determinants of this process.
We employed the CLC-Ka isoform because it showsmuch higher current
expression in oocytes compared to CLC-Kb. Since both isoforms are po-
tentiated by NFA by similar mechanisms, our ﬁndings are likely relevant
for CLC-Kb as well.
We identiﬁed two adjacent residues belonging to the I–J loop, F256
and N257, that are involved in the CLC-Kmodulation by NFA. In Xenopus
oocytes, F256A induces a huge NFA potentiation in CLC-Ka and a tran-
sient potentiation in CLC-K1, which is normally only blocked byNFA. Im-
portantly, it partially recovers the biphasic response to NFA of CLC-Ka in
HEK293 cells. Surprisingly, the CLC-Ka N257A mutant expressed in oo-
cytes shows very large and voltage-independent currents, which are
only blocked by NFA (KD ~ 1 μM). By non-stationary noise analysis and
single channel measurements we established that the potentiation of
F256A and the inhibition of N257A by NFA reﬂect a change of the openprobability of the channel, while NFA does not affect the single-channel
conductance of these mutants. The single channel analysis conﬁrmed
that the open-probability of CLC-Ka in oocytes is extremely small
(b1%). Interestingly, in the presence of NFA, the open-probability of mu-
tant F256A CLC-Ka reaches values around 20%, becomingmore similar to
what is observed for the channel expressed in HEK cells [26].
Interestingly, the conductance estimated for F256A is similar to that
of WT CLC-Ka [14,25] and roughly twice the value obtained for N257A
from CPA induced current relaxations by non-stationary noise analysis.
Regarding N257A, single channel recordings showed several conduc-
tance levels andmuch slower gating kinetics.We speculate that theﬂick-
ery open single channel current of F256A (Fig. 4B, C) could be caused by
the presence of various conductance levels, which are not temporally re-
solved, and that the mutant N257A slows down these ﬂuctuations,
resulting in well resolved conductance levels. Further experiments are
needed to clarify this interesting detail. We cannot, however, rule out
thatmutant N257A directly alters the channel conductance, even though
N257 is located far away from the channel pore.
WT/barttin N257A/barttin N257A
)0(I/)AFN
M
µ
002(I
0.1
1
CLC-K1
3 µA  
100 ms
Fig. 11. NFA afﬁnity of N257A CLC-K1 is comparable to that of WT CLC-K1. Comparison
of normalized currents of WT CLC-K1/barttin (n = 5), N257A/barttin (n = 3), and
N257A (n = 5) at 200 μM NFA normalized to the current recorded in control condition.
On top of the ﬁgure typical current traces of WT/barttin, N257A/barttin, and N257A CLC-
K1 (from left to right).
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ly involved in NFA binding, but we establish that the I–J loop harboring
them is involved in themechanism that underlies NFA potentiation. The
NFA potentiation of F256A (and of WT CLC-Ka expressed in oocytes)
clearly reﬂects a conformational change of the protein. The NFA binding
site mediating the potentiation (site “P”) is likely different from the
binding site mediating block of CLC-K1, WT CLC-Ka, and all CLC-Ks in
HEK293 cells (site “B”) [24,26]. We believe that the dramatic block of
N257A CLC-Ka is mediated by the normally potentiating site “P” and
not by the regular blocking site “B”. Indeed, block of N257A occurs
with high afﬁnity, as the potentiation of F256A and it involves a slow
conformational change as evidenced by the continuous reduction of
currents after washout (Fig. 8C).
Apart from pointing to a region that is involved in NFA potentiation
the two mutants F256A and N257A teach us an important lesson. The
fact that a relatively minor point mutation far away from the channel
pore is able to hugely increase the open probability (popen) of the chan-
nel, shows that popen is a fragile property. Thus, the very large popen of
CLC-K channels expressed in HEK293 cells [10,11,26] compared to the
small popen in oocytes [14] might be caused by a relatively subtle differ-
ence between the two systems.
F256 and N257 as well as the extracellular Ca2+ binding site [23,27]
belong to the I–J loop which has a peculiar role in the structure of CLC
proteins [28]. Additionally, the residue responsible for acidic block of
CLC-Ks, H497 [14], is positioned quite close to this loop. Our study
shows that the I–J loop is important for the regulation of CLC-K channels
by extracellular ligands. Thus, this loopmay represent an ideal target for
potential drugs aimed at the potentiation of CLC-K channels in their na-
tive environment.
Finally, we demonstrated that the barttin subunit is required for the
NFA activation of CLC-K channels. Thus, in addition to barttin's known
roles [5,10–12], it also participates in the pharmacological modulation
of CLC-K channels. Thus, the different response to NFA of CLC-Ks
expressed in HEK293 cells might depend on a different interaction
channel/barttin in oocytes compared tomammalian cells. In conclusion,
in this work we identiﬁed two suitable targets for drugs: the I–J loop of
the channel and its barttin subunit.
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